Question 1

What is the catalog number for APOD CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

The catalog number for APOD CRISPRa sgRNA lentivector (set of three targets)(Human) is 12181121.

Question 2

What sizes are available for APOD CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

APOD CRISPRa sgRNA lentivector (set of three targets)(Human) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is APOD CRISPRa sgRNA lentivector (set of three targets)(Human) in stock?

Accepted Answer

APOD CRISPRa sgRNA lentivector (set of three targets)(Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 5

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 6

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

APOD CRISPRa sgRNA lentivector (set of three targets)(Human)

Product Specifications

Gene Name

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Cytokeratin 17 (KRT17/778), 1mg/mL

Histone H1 (Pan Nuclear Marker) (N/A), CF405S conjugate, 0.1mg/mL

IDH1 (IDH1/1152), CF594 conjugate, 0.1mg/mL

CD147 (BSG/963), CF740 conjugate, 0.1mg/mL

Prolactin (Pituitary Tumor Marker) (PRL/2641), CF405S conjugate, 0.1mg/mL

Anti-Alpha 1 Acid Glycoprotein/ORM1 Antibody Picoband® (FITC Conjugate)